Boston, Massachusetts, United States The venture was found in North America in United States. The main office of represented VC is situated in the Boston.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Adage Capital Management, startups are often financed by Morgenthaler Ventures, QuestMark Partners, Lightspeed Venture Partners. The meaningful sponsors for the fund in investment in the same round are Rock Springs Capital, T. Rowe Price, OrbiMed. In the next rounds fund is usually obtained by Redmile Group, Morgenthaler Ventures, SightLine Partners.
The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this Adage Capital Management works on 33 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Adage Capital Management is more than 1 billion dollars. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2014.
Among the most popular portfolio startups of the fund, we may highlight AveXis, Tanium, MuleSoft. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
The fund was created by Phillip Gross, Robert George Atchinson. The overall number of key employees were 4.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Menlo Micro | $150M | 09 Mar 2022 | Irvine, California, United States | ||
Scout Bio | $33M | 19 Oct 2021 | Philadelphia, Pennsylvania, United States | ||
Pyramid Biosciences | $33M | 15 Oct 2021 | Massachusetts, United States | ||
Beckley Psytech | $79M | 15 Aug 2021 | South Oxfordshire, England, United Kingdom | ||
SiMa.ai | $80M | 11 May 2021 | San Jose, California, United States | ||
Arch Oncology | $105M | 27 Apr 2021 | California, United States | ||
| $100M | 13 Apr 2021 | New York, New York, United States | |||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
HemoShear Therapeutics | $40M | 10 Feb 2021 | Charlottesville, Virginia, United States |
– Beckley Psytech an Oxford, England-based private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines closed an $80m Series B financing.
– The round was led by Integrated with participation from Prime Movers Labs, Adage Capital Management, Palo Santo; Delphi VC; Leafy Tunnel; Negev Capital; and existing investor Bicycle Day Ventures.
– The company intends to use the funds to complete the ongoing Phase 1b trial with low-dose psilocybin in patients suffering from SUNHA, a rare and debilitating headache condition estimated to affect 45,000 people in the US and Europe, and to initiate a Phase 1 dose-ranging study on a novel formulation of intranasal 5-MeO-DMT before starting a Phase 2 trial in Treatment Resistant Depression, and expand its pipeline with new, unique and proprietary psychedelic compounds.
– Gopuff, the go-to platform for consumers’ immediate everyday needs, announced that it has secured $1 billion in new funding at a $15 billion valuation.
– Some of the world’s foremost technology investors participated in the round, including new investors Blackstone’s Horizon platform, Guggenheim Investments, Hedosophia, MSD Partners, and Adage Capital, along with existing investors Fidelity Management and Research Company, Softbank Vision Fund 1, Atreides Management, and Eldridge.
– With these new funds, Gopuff will continue to accelerate its strategic business initiatives including further geographic expansion across North America, deeper expansion into the UK and across Europe, hiring top-tier local talent, and focusing on enhancing its technology to continue to deliver an exceptional customer experience.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Menlo Micro | $150M | 09 Mar 2022 | Irvine, California, United States | ||
Scout Bio | $33M | 19 Oct 2021 | Philadelphia, Pennsylvania, United States | ||
Pyramid Biosciences | $33M | 15 Oct 2021 | Massachusetts, United States | ||
Beckley Psytech | $79M | 15 Aug 2021 | South Oxfordshire, England, United Kingdom | ||
SiMa.ai | $80M | 11 May 2021 | San Jose, California, United States | ||
Arch Oncology | $105M | 27 Apr 2021 | California, United States | ||
| $100M | 13 Apr 2021 | New York, New York, United States | |||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
HemoShear Therapeutics | $40M | 10 Feb 2021 | Charlottesville, Virginia, United States |
